Sign in

CIK 0001006045 · Non-accelerated filer<br>Smaller reporting company

IRIDEX CORP

Sign in to watch
Ticker
IRIX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Jan 3
Incorporated
DE
Entity type
operating
EIN
770210467
Phone
6509404700
Business address
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA, 94043
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Director bought 20,000 shares at $0.97 ($19,372)
  4. 4 Open-market buy President and CEO bought 250 shares at $0.96 ($240)
  5. 4 Open-market buy Director bought 30,000 shares at an average $0.97 ($29,121)
  6. 4 Open-market buy Chief Financial Officer bought 245 shares at $0.97 ($236)
  7. 4 Open-market buy Chief Financial Officer bought 835 shares at an average $0.98 ($822)
  8. 4 Open-market buy Chief Financial Officer bought 1,500 shares at $0.97 ($1,455)
  9. 4 Open-market buy Chief Financial Officer bought 200 shares at an average $1.00 ($199)
  10. 4 Open-market buy Chief Financial Officer bought 200 shares at $0.99 ($197)
  11. 4 Open-market buy Chief Financial Officer bought 200 shares at $0.95 ($190)
  12. 4 Open-market buy Chief Financial Officer bought 100 shares at $1.00 ($100)
  13. 4 Shares withheld for taxes President and CEO gave up 14,310 shares (to pay taxes)
  14. 4 Open-market buy Chief Financial Officer bought 100 shares at $1.00 ($100)
  15. 4 Open-market buy Chief Financial Officer bought 200 shares at an average $1.00 ($201)
  16. 4 Open-market buy Director bought 17,500 shares at an average $1.09 ($19,009)
  17. 4 Open-market buy Chief Financial Officer bought 460 shares at $1.10 ($506)
  18. 4 Open-market buy Chief Financial Officer bought 1,305 shares at an average $1.11 ($1,451)
  19. 4 Open-market buy Chief Financial Officer bought 100 shares at $1.16 ($116)
  20. 4 Open-market buy Chief Financial Officer bought 100 shares at $1.15 ($115)

Page 5 of 31 · 608 filings